Table 4.
Summary of SMDs with 95% Confidence Intervals and Measure of Heterogeneity (I2) in Triglycerides, Total Cholesterol, LDL, and HDL between Patients With AMD or Specific Stages of AMD Compared with Controls
| SMD [95% Confidence Interval]; I2 |
||||
|---|---|---|---|---|
| All AMD | Early/Intermediate Dry AMD | Advanced Dry AMD | Advanced Wet AMD | |
| Triglycerides | −0.03 [−0.06, 0.01]; 99.3% | −0.03 [−0.06, −0.01]; 88.8% | −0.03 [−0.94, 0.88]; 19.6% | −0.19 [−0.89, 0.51]; 96.0% |
| Total cholesterol | −0.01 [−0.02, 0.00]; 75.4% | −0.01 [−0.03, 0.00]; 93.7% | −0.01 [−0.01, 0.00]; 0.0% | 0.08 [−0.04, 0.20]; 43.3% |
| LDL | −0.00 [−0.01, 0.00]; 84.9% | −0.01 [−0.02, 0.00]; 90.0% | −0.10 [−1.72, 1.52]; 0.0% | 0.33 [0.04, 0.62]; 53.3% |
| HDL | 0.19 [−0.10, 0.48]; 100.0% | 0.07 [0.04, 0.11]; 99.0% | 0.01 [−0.04, 0.07]; 0.0% | −0.06 [−0.18, 0.06]; 23.6% |
AMD= age-related macular degeneration; HDL = high-density lipoprotein; LDL = low-density lipoprotein; SMD = standardized mean difference.